SP
IPHA

SmartHarvest Portfolios’s Innate Pharma IPHA Stock Holding History

SmartHarvest Portfolios’s Portfolio IPHA Stock Details IPHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.7K Buy
+23,750
New +$39.3K 0.01% 432

Other funds holding IPHA

FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

SmartHarvest Portfolios's IPHA Position: Q2 2026 in Review

SmartHarvest Portfolios opened a new position in Innate Pharma (IPHA) in Q2 2026: 23,750 shares worth $43.7K. The stake represents 0.01% of the portfolio and ranks #432 among its holdings.

3 funds tracked by Wall St. Rank hold IPHA as of Q2 2026.

  • SmartHarvest Portfolios held 23,750 shares of Innate Pharma worth $43.7K as of Q2 2026.
  • Innate Pharma was a new SmartHarvest Portfolios position in Q2 2026.
  • Innate Pharma made up 0.01% of SmartHarvest Portfolios's portfolio in Q2 2026, its #432 holding.
  • 3 funds tracked by Wall St. Rank held Innate Pharma as of Q2 2026.

Based on SmartHarvest Portfolios's 13F filing for Q2 2026, filed 4 Aug 2026.